On June 8 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of first quarter 2016 and informed about other recent activities within the company.
During the presentation Salvis Lapiņš noted that Olainfarm has started working on acquisition idea in Belarus, while there are no serious acquisition plans in Russia at the moment. As previously announced, there are two more acquisition ideas that are currently in advance state. During the webinar Salvis Lapiņš also elaborated on profit prognoses for 2016 and explained that decrease in profit prognoses are associated with Ukrainian provisions in amount of 4.5 million EUR.
The recorded “Olainfarm” webinar is available online: http://ej.uz/OLF_Q1_2016_rec, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: http://ej.uz/OLF_Q1_2016_PDF_LV.
Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777